Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement;Ítems de referencia para publicar Revisiones Sistemáticas y Metaanálisis: La Declaración PRISMA

Revista Espanola de Nutricion Humana y Dietetica

Volumn 18, Issue 3, 2014, Pages 172-181

  Moher, David ^a,b   Liberati, Alessandro ^c,d   Tetzlaff, Jennifer ^a   Altman, Douglas G ^e   Antes, Gerd ^f   Atkins, David ^g   Barbour, Virginia ^h   Barrowman, Nick ⁱ   Berlin, Jesse A ^j   Clark, Jocalyn ^h   Clarke, Mike ^k,l   Cook, Deborah ^m   D'Amico, Roberto ^c,d   Deeks, Jonathan J ⁿ   Devereaux, P J ^m   Dickersin, Kay ^o   Egger, Matthias ^p   Ernst, Edzard ^q   Gøtzsche, Peter C ^r   Grimshaw, Jeremy ^a   Guyatt, Gordon ^m   Higgins, Julian ^s   Ioannidis, John P A ^t   Kleijnen, Jos ^u,v   Lang, Tom ^w   Magrini, Nicola ^x   McNamee, David ^y   Moja, Lorenzo ^d   Mulrow, Cynthia ^z   Napoli, Maryann ^aa   Oxman, Andy ^ab   Pham, Ba' ^ac,ad   Rennie, Drummond ^ae   Sampson, Margaret ⁱ   Schulz, Kenneth F ^af   Shekelle, Paul G ^ag   Tovey, David ^ah,ai   Tugwell, Peter ^b   more..

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f UNIVERSITY OF FREIBURG   (Germany)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

^h PLoS Medicine ^*  (United Kingdom)

ⁱ CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^j JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^k UK COCHRANE CENTRE   (United Kingdom)

^l TRINITY COLLEGE DUBLIN   (Ireland)

^m MCMASTER UNIVERSITY   (Canada)

ⁿ UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^o JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^p UNIVERSITY OF BERN   (Switzerland)

^q PENINSULA MEDICAL SCHOOL   (United Kingdom)

^r Nordic Cochrane Centre   (Denmark)

^s MRC BIOSTATISTICS UNIT   (United Kingdom)

^t UNIVERSITY OF IOANNINA   (Greece)

^u KLEIJNEN SYSTEMATIC REVIEWS LTD   (United Kingdom)

^v MAASTRICHT UNIVERSITY   (Netherlands)

^w Tom Lang Communications and Training   (United States)

^x NHS Centre for the Evaluation of the Effectiveness of Health Care CeVEAS   (Netherlands)

^y THE LANCET   (United Kingdom)

^z Annals of Internal Medicine   (United States)

^aa Center for Medical Consumers   (United States)

^ab Norwegian Health Services Research Centre   (Norway)

^ac UNIVERSITY OF TORONTO   (Canada)

^ad GLAXOSMITHKLINE   (Canada)

^ae UNIVERSITY OF CALIFORNIA   (United States)

^af FAMILY HEALTH INTERNATIONAL   (United States)

^ag Southern California Evidence Based Practice Center   (Canada)

^ah Palliative and Supportive Care Review Group   (United Kingdom)

^ai British Medical Journal Technology Assessment Group   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; META ANALYSIS (TOPIC); SYSTEMATIC REVIEW (TOPIC);

EID: 84931317927     PISSN: 21731292     EISSN: None     Source Type: Journal    
DOI: 10.14306/renhyd.18.3.114     Document Type: Article

References (42)

1. Oxman AD, Cook DJ, Guyatt GH. Users' guides to the medical literature. VI. How to use an overview. Evidence-Based Medicine Working Group. JAMA J Am Med Assoc. 1994; 272: 1367-71.
2. Swingler GH, Volmink J, Ioannidis JPA. Number of published systematic reviews and global burden of disease: database analysis. BMJ. 2003; 327: 1083-4.
3. Canadian Institutes of Health Research. Randomized controlled trials registration/application checklist (12/2006) [portal en internet]. 2006 [citado 19 de mayo de 2009]. Disponible en: http://www.cihr-irsc. gc.ca/e/documents/rct_reg_e.pdf
4. Young C, Horton R. Putting clinical trials into context. Lancet. 2005; 366: 107-8.
5. Mulrow CD. The medical review article: state of the science. Ann Intern Med. 1987; 106: 485-8.
6. Sacks HS, Berrier J, Reitman D, Ancona-Berk VA, Chalmers TC. Meta-analyses of randomized controlled trials. N Engl J Med. 1987; 316: 450-5.
7. Sacks HS, Reitman D, Pagano D, Kupelnick B. Metaanalysis: an update. Mt Sinai J Med N Y. 1996; 63: 216-24.
8. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet. 1999; 354: 1896-900.
9. Green S, Higgins J. Glossary. Cochrane handbook for systematic reviews of interventions 4.2.5. The Cochrane Collaboration [portal en internet]. 2005 [citado 19 de mayo de 2009]. Disponible en: http://www.cochrane. org/resources/glossary.htm
10. Strech D, Tilburt J. Value judgments in the analysis and synthesis of evidence. J Clin Epidemiol. 2008; 61: 521-4.
11. Moher D, Tsertsvadze A. Systematic reviews: when is an update an update? Lancet. 2006; 367: 881-3.
12. University of York. Centre for Reviews and Dissemination [portal en internet]. 2009 [citado 19 de mayo de 2009]. Disponible en: http://www.york.ac.uk/inst/crd/.
13. The Joanna Briggs Institute. Protocols&work in progress [portal en internet]. 2008 [citado 19 de mayo de 2009]. Disponible en: http://www.joannabriggs.edu. au/pubs/systematic_reviews_prot.php.
14. De Angelis C, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. CMAJ Can Med Assoc J J Assoc Medicale Can. 2004; 171: 606-7.
15. Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet. 2004; 363: 1341-5.
16. Bagshaw SM, McAlister FA, Manns BJ, Ghali WA. Acetylcysteine in the prevention of contrast-induced nephropathy: a case study of the pitfalls in the evolution of evidence. Arch Intern Med. 2006; 166: 161-6.
17. Biondi-Zoccai GGL, Lotrionte M, Abbate A, Testa L, Remigi E, Burzotta F, et al. Compliance with QUOROM and quality of reporting of overlapping meta-analyses on the role of acetylcysteine in the prevention of contrast associated nephropathy: case study. BMJ. 2006; 332: 202-9.
18. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6:e1000100.
19. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001; 134: 663-94.
20. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med. 2003; 138: W1-12.
21. Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med. 2007; 147: W163-194.
22. Moher D, Tetzlaff J, Tricco AC, Sampson M, Altman DG. Epidemiology and reporting characteristics of systematic reviews. PLoS Med. 2007; 4: e78.
23. Bhandari M, Morrow F, Kulkarni AV, Tornetta P. Metaanalyses in orthopaedic surgery. A systematic review of their methodologies. J Bone Joint Surg Am. 2001; 83-A: 15-24.
24. Kelly KD, Travers A, Dorgan M, Slater L, Rowe BH. Evaluating the quality of systematic reviews in the emergency medicine literature. Ann Emerg Med. 2001; 38: 518-26.
25. Richards D. The quality of systematic reviews in dentistry. Evid Based Dent. 2004; 5: 17.
26. Choi PT, Halpern SH, Malik N, Jadad AR, Tramèr MR, Walder B. Examining the evidence in anesthesia literature: a critical appraisal of systematic reviews. Anesth Analg. 2001; 92: 700-9.
27. Delaney A, Bagshaw SM, Ferland A, Manns B, Laupland KB, Doig CJ. A systematic evaluation of the quality of meta-analyses in the critical care literature. Crit Care Lond Engl. 2005; 9: R575-582.
28. Dickersin K. Publication bias: Recognizing the problem, understanding its origins and scope, and preventing harm. En: Rothstein HR, Sutton AJ, Borenstein M. Publication Bias in Meta-Analysis: Prevention, Assessment and Adjustments. 1 edition. Chichester, England; Hoboken, NJ: Wiley; 2005. p. 11-33.
29. Utton AJ. Evidence concerning the consequences of publication and related biases. En: Rothstein HR, Sutton AJ, Borenstein M. Publication Bias in Meta-Analysis: Prevention, Assessment and Adjustments. 1 edition. Chichester, England Hoboken, NJ: Wiley; 2005. p. 175-92.
30. Lau J, Ioannidis JPA, Terrin N, Schmid CH, Olkin I. The case of the misleading funnel plot. BMJ. 2006; 333: 597-600.
31. Ladabaum U, Chopra CL, Huang G, Scheiman JM, Chernew ME, Fendrick AM. Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer. A cost-effectiveness analysis. Ann Intern Med. 2001; 135: 769-81.
32. Deeks JJ. Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests. BMJ. 2001; 323: 157-62.
33. Altman DG. Systematic reviews of evaluations of prognostic variables. BMJ. 2001; 323: 224-8.
34. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet. 2001; 29: 306-9.
35. Lavis J, Davies H, Oxman A, Denis J-L, Golden-Biddle K, Ferlie E. Towards systematic reviews that inform health care management and policy-making. J Health Serv Res Policy. 2005; 10 Suppl 1: 35-48.
36. Stewart LA, Clarke MJ. Practical methodology of metaanalyses (overviews) using updated individual patient data. Cochrane Working Group. Stat Med. 1995; 14: 2057-79.
37. Moja LP, Telaro E, D'Amico R, Moschetti I, Coe L, Liberati A. Assessment of methodological quality of primary studies by systematic reviews: results of the metaquality cross sectional study. BMJ. 2005; 330: 1053.
38. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008; 336: 924-6.
39. Schünemann HJ, Jaeschke R, Cook DJ, Bria WF, El-Solh AA, Ernst A, et al. An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med. 2006; 174: 605-14.
40. Chan A-W, Hróbjartsson A, Haahr MT, Gøtzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA J Am Med Assoc. 2004; 291: 2457-65.
41. Chan A-W, Krleza-Jeric K, Schmid I, Altman DG. Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. CMAJ Can Med Assoc J J Assoc Medicale Can. 2004; 171: 735-40.
42. Silagy CA, Middleton P, Hopewell S. Publishing protocols of systematic reviews: comparing what was done to what was planned. JAMA J Am Med Assoc. 2002; 287: 2831-4.